What Does it Mean?

A $125,000 machine from Knome aims to take the pain out of genome analysis. As The New York Times reports, the cost of sequencing a human genome is dropping, though analysis is still an issue and the machine, called the knoSYSTM100, may help researchers interpret what those sequences mean. For an extra $25,000 a year, users can get software updates and technical support.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.